REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio de Patologia Susana Restrepo S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio de Patologia Susana Restrepo S.A.S. Profile Updated: April 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio de Patologia Susana Restrepo S.A.S. is a company based in Colombia, with its head office in Medellin. It operates in the Diagnostic Imaging Centers sector. It was first established on May 20, 2011. It currently has a total number of 8 (2024) employees. There was a net sales revenue increase of 2.94% reported in Laboratorio de Patologia Susana Restrepo S.A.S.’s latest financial highlights for 2023. During that time, Laboratorio de Patologia Susana Restrepo S.A.S.’s total assets grew by 15.6%. The net profit margin of Laboratorio de Patologia Susana Restrepo S.A.S. increased by 3.47% in 2023.

Headquarters
Calle 51 45 93 Consultorio 211
Medellin; Antioquia;

Contact Details: Purchase the Laboratorio de Patologia Susana Restrepo S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio de Patologia Susana Restrepo S.A.S. report to view the information.
Outstanding Shares:
Purchase the Laboratorio de Patologia Susana Restrepo S.A.S. report to view the information.
Incorporation Date:
May 20, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio de Patologia Susana Restrepo S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
2.94%
Total operating revenue
2.94%
Operating profit (EBIT)
27.76%
EBITDA
27.03%
Net Profit (Loss) for the Period
39.42%
Total assets
15.6%
Total equity
10.96%
Operating Profit Margin (ROS)
5.03%
Net Profit Margin
3.47%
Return on Equity (ROE)
4.91%
Quick Ratio
-0.6%
Cash Ratio
0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?